Healing Portfolios: Five Pharma Outperformers That Crushed Sectoral Index Since Last Diwali
· NDTV Profit
Several developments shaped investor sentiment towards the pharmaceutical sector, including the expiry of the semaglutide patent in India, developments around US drug tariffs and growing opportunities in CDMO.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- A market-wide development: it reaches beyond any single stock.
- Sectors in the story: Pharma & Healthcare.
Pharma & Healthcare
1M +0.9% · 3M -0.8%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 crore
HRV Pharma acquires German firm Phatebo, enters finished formulations biz
Q2 Results Live: Pfizer's One-Time Gain Lifts Profit; SBI Asset Quality Improves; Solar Industries Profit Zooms 79%
Stocks to watch: ITC, Lupin, NBCC, SBI, Dr Reddy's, Bosch, Ola Electric
Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun Pharma